These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 1662896

  • 1. Comparative pharmacokinetics of ciprofloxacin and temafloxacin in humans: a review.
    Sorgel F, Naber KG, Kinzig M, Mahr G, Muth P.
    Am J Med; 1991 Dec 30; 91(6A):51S-66S. PubMed ID: 1662896
    [Abstract] [Full Text] [Related]

  • 2. Penetration of temafloxacin into body tissues and fluids.
    Sörgel F.
    Clin Pharmacokinet; 1992 Dec 30; 22 Suppl 1():57-63. PubMed ID: 1319872
    [Abstract] [Full Text] [Related]

  • 3. Effects of temafloxacin and ciprofloxacin on the pharmacokinetics of caffeine.
    Mahr G, Sörgel F, Granneman GR, Kinzig M, Muth P, Patterson K, Fuhr U, Nickel P, Stephan U.
    Clin Pharmacokinet; 1992 Dec 30; 22 Suppl 1():90-7. PubMed ID: 1319876
    [Abstract] [Full Text] [Related]

  • 4. Influence of renal function on the pharmacokinetics of lomefloxacin compared with other fluoroquinolones.
    Blum RA.
    Am J Med; 1992 Apr 06; 92(4A):18S-21S. PubMed ID: 1316065
    [Abstract] [Full Text] [Related]

  • 5. Effect of antacid medication on the pharmacokinetics of temafloxacin.
    Granneman GR, Stephan U, Birner B, Sörgel F, Mukherjee D.
    Clin Pharmacokinet; 1992 Apr 06; 22 Suppl 1():83-9. PubMed ID: 1319875
    [Abstract] [Full Text] [Related]

  • 6. A review of the pharmacokinetic profile of temafloxacin.
    Dudley MN.
    J Antimicrob Chemother; 1991 Dec 06; 28 Suppl C():55-64. PubMed ID: 1664830
    [Abstract] [Full Text] [Related]

  • 7. Comparative pharmacokinetic disposition of fluoroquinolones in the lung.
    Wise R, Baldwin DR, Andrews JM, Honeybourne D.
    J Antimicrob Chemother; 1991 Dec 06; 28 Suppl C():65-71. PubMed ID: 1664831
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics and biliary elimination of temafloxacin in pigs.
    Jehl F, Bresler L, Koechlin C, Merle-Melet M, Didelot JP, Hazebroucq J.
    J Antimicrob Chemother; 1992 Aug 06; 30(2):189-96. PubMed ID: 1328135
    [Abstract] [Full Text] [Related]

  • 9. Comparison of sparfloxacin, temafloxacin, and ciprofloxacin for prophylaxis and treatment of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.
    Cagni A, Chuard C, Vaudaux PE, Schrenzel J, Lew DP.
    Antimicrob Agents Chemother; 1995 Aug 06; 39(8):1655-60. PubMed ID: 7486895
    [Abstract] [Full Text] [Related]

  • 10. Effect of cimetidine on the pharmacokinetics of temafloxacin.
    Sörgel F, Granneman GR, Stephan U, Locke C.
    Clin Pharmacokinet; 1992 Aug 06; 22 Suppl 1():75-82. PubMed ID: 1319874
    [Abstract] [Full Text] [Related]

  • 11. Kinetic disposition of temafloxacin and ciprofloxacin in a murine model of pneumococcal pneumonia. Relevance for drug efficacy.
    Vallée E, Azoulay-Dupuis E, Bauchet J, Pocidalo JJ.
    J Pharmacol Exp Ther; 1992 Sep 06; 262(3):1203-8. PubMed ID: 1326627
    [Abstract] [Full Text] [Related]

  • 12. The influence of age on the pharmacokinetics of temafloxacin.
    Granneman GR, Guay DR.
    Am J Med; 1991 Dec 30; 91(6A):71S-75S. PubMed ID: 1662898
    [Abstract] [Full Text] [Related]

  • 13. The effect of food on the bioavailability of temafloxacin. A review of 3 studies.
    Granneman GR, Mukherjee D.
    Clin Pharmacokinet; 1992 Dec 30; 22 Suppl 1():48-56. PubMed ID: 1319871
    [Abstract] [Full Text] [Related]

  • 14. The in-vitro activity, pharmacokinetics and tissue penetration of temafloxacin.
    Nye K, Shi YG, Andrews JM, Ashby JP, Wise R.
    J Antimicrob Chemother; 1989 Sep 30; 24(3):415-24. PubMed ID: 2808194
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of temafloxacin in humans after multiple oral doses.
    Granneman GR, Carpentier P, Morrison PJ, Pernet AG.
    Antimicrob Agents Chemother; 1992 Feb 30; 36(2):378-86. PubMed ID: 1318680
    [Abstract] [Full Text] [Related]

  • 16. Lomefloxacin and temafloxacin: two new fluoroquinolone antimicrobials.
    Symonds WT, Nix DE.
    Clin Pharm; 1992 Sep 30; 11(9):753-66. PubMed ID: 1325892
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of temafloxacin after multiple oral administration.
    Granneman GR.
    Clin Pharmacokinet; 1992 Sep 30; 22 Suppl 1():14-23. PubMed ID: 1319867
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of temafloxacin in patients with liver impairment.
    Granneman GR, Mahr G, Locke C, Nickel P, Kirch W, Fabian W, Kinzig M, Naber KG, Sörgel F.
    Clin Pharmacokinet; 1992 Sep 30; 22 Suppl 1():24-32. PubMed ID: 1319868
    [Abstract] [Full Text] [Related]

  • 19. Hepatobiliary elimination of temafloxacin.
    Sörgel F, Granneman GR, Mahr G, Kujath P, Fabian W, Nickel P.
    Clin Pharmacokinet; 1992 Sep 30; 22 Suppl 1():33-42. PubMed ID: 1319869
    [Abstract] [Full Text] [Related]

  • 20. Effects of new quinolones on Mycoplasma pneumoniae-infected hamsters.
    Arai S, Gohara Y, Akashi A, Kuwano K, Nishimoto M, Yano T, Oizumi K, Takeda K, Yamaguchi T.
    Antimicrob Agents Chemother; 1993 Feb 30; 37(2):287-92. PubMed ID: 8383942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.